| Abacavir/ dolutegravir/ lamivudine |
ViiV Healthcare Company |
6/7/2023 |
|
| Abatacept |
BMS |
2/14/2017 |
|
| Acetaminophen |
Mallinckrodt |
7/11/2016 |
|
| Afatinib |
Boehringer Ingelheim Pharmaceuticals, Inc. |
3/8/2022 |
|
| Aflibercept |
Regeneron Pharmaceuticals |
10/18/2022 |
|
| Albuterol |
GlaxoSmithKline |
8/27/2008 |
|
| Alfuzosin |
Sanofi Aventis |
9/7/2010 |
|
| Aliskiren |
Noden Pharma DAC |
10/3/2017 |
|
| Almotriptan |
Johnson & Johnson Pharmaceutical Research & Development |
1/13/2009 |
|
| Amphetamine |
Shire |
8/18/2019 |
|
| Anastrozole |
AstraZeneca |
11/14/2007 |
|
| Apremilast |
Amgen Inc. |
4/22/2024 |
|
| Aripiprazole |
Otsuka |
11/14/2007 |
|
| Asenapine |
Forest Labs |
3/3/2015 |
|
| Atazanavir |
BMS |
6/23/2015 |
|
| Atezolizumab |
Genentech |
9/22/2020 |
|
| Axitinib |
Pfizer, Inc. |
7/2/2024 |
|
| Azelastine/Fluticasone and Azelastine |
Meda Pharmaceuticals |
3/23/2015 |
|
| Bendamustine |
Cephalon |
5/24/2012 |
|
| Bezlotoxumab |
Merck Sharpe and Dohme |
5/12/2023 |
|
| Bicalutamide |
AstraZeneca |
9/19/2008 |
|
| Bivalirudin |
The Medicines Company |
6/17/2009 |
|
| Blinatumomab |
Amgen |
6/13/2023 |
|
| Bosutinib |
PF Prism, C.V. |
9/7/ 2023 |
|
| Bortezomib |
Millennium Pharmaceuticals |
8/14/2015 |
|
| Brentuximab vedotin |
Seagen, Inc. |
11/18/2022 |
|
| Brexpiprazole |
Otsuka Pharmaceutical Development & Commercialization |
5/2/2024 |
|
| Budesonide/Formoterol |
AstraZeneca |
1/25/2017 |
|
| Cabazitaxel |
Sanofi Aventis |
5/18/2017 |
|
| Calcipotriene/Betamethasone |
Leo Pharma |
7/15/2019 |
|
| Canagliflozin |
Janssen Pharmaceuticals, Inc. |
12/9/2024 |
|
| Candesartan |
AstraZeneca Pharmaceuticals LP |
7/20/2009 |
|
| Capecitabine |
Hoffman-La Roche, Inc. |
8/28/2013 |
|
| Caspofungin |
Merck & Co., Inc. |
4/15/2008 |
|
| Cetirizine |
Nicox Ophthalmics |
8/29/16 |
|
| Clopidogrel |
Sanofi Aventis |
1/20/2011 |
|
| Cobimetinib |
Genentech, Inc. |
7/19/2022 |
|
| Colesevelam |
Daiichi Sankyo Pharma |
2/17/2009 |
|
| Crisaborole |
Pfizer |
2/21/2020 |
|
| Cysteamine |
Horizon |
12/12/2017 |
|
| Dabigatran |
Boehringer Ingelheim Pharmaceuticals, Inc. |
2/12/2021 |
|
| Dabrafenib |
Novartis |
2/9/2023 |
|
| Dapagliflozin |
AstraZeneca AB |
5/30/2024 |
|
| Darunavir |
Tibotec |
6/7/2011 |
|
| Deutetrabenazine |
Teva Branded Pharmaceutical Products |
5/5/2021 |
/
|
| Dexmedetomidine |
Hospira |
3/12/2013 |
|
| Difluprednate |
Alcon |
3/21/2013 |
|
| Docetaxel |
Sanofi Aventis |
3/17/2010 |
|
| Dulaglutide |
Eli Lilly and Company |
October 4, 2022 |
|
| Duloxetine |
Eli Lilly |
7/2/2012 |
|
| Efavirenz |
BMS |
1/29/2013 |
|
| Eltrombopag |
Novartis |
8/14/2015 |
|
| Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide |
Gilead Sciences, Incorporated |
9/13/2021 |
|
| Empagliflozin/Empagliflozin and Metformin hydrochloride |
Boehringer Ingelheim Pharmaceuticals |
6/9/2023 |
|
| Entecavir |
BMS |
12/5/2013 |
|
| Eplerenone |
Pfizer |
10/24/2007 |
|
| Eribulin Mesylate |
Eisai, Inc. |
8/9/2022 |
|
| Erlotinib |
OSI Pharmaceuticals |
3/18/2015 |
|
| Esomeprazole |
AstraZeneca LP |
5/1/2009 |
|
| Eszopiclone |
Sunovion |
6/29/2012 |
|
| Etravirine |
Janssen |
6/21/2018 |
|
| Everolimus |
Novartis |
7/10/2012 |
|
| Exenatide |
AstraZeneca |
4/1/2021 |
|
| Ezetimibe |
Schering Corporation |
2/14/2008 |
|
| Famciclovir |
Novartis |
9/21/2009 |
|
| Fenfluramine hydrochloride |
Zogenix, Inc |
3/23/2022 |
|
| Ferric Oxyhydroxide |
Vifor Fresenius Medical Care Renal Pharma France |
6/1/2021 |
|
| Fesoterodine |
Pfizer |
6/3/2021 |
|
| Fidaxomicin |
Cubist |
12/13/2019 |
|
| Finafloxacin |
Alcon |
8/25/2014 |
|
|
Fingolimod
|
Novartis |
4/16/2018 |
|
| Fluticasone & Fluticasone/Salmeterol |
Teva Pharmaceutical Industries Ltd. |
6/10/2021 |
|
| Fluticasone furoate vilanterol trifenatate |
GlaxoSmithKline |
4/26/2023 |
|
| Fosamprenavir |
ViiV Healthcare |
1/10/2012 |
|
| Fosaprepitant |
Merck |
3/23/2018 |
|
| Fulvestrant |
AstraZeneca |
2/1/2011 |
|
| Gatifloxacin |
Allergan |
5/19/2009 |
|
| Glecaprevir/Pibrentasvir |
AbbVie, Inc. |
5/18/2021 |
|
| Guanfacine |
Shire |
10/17/2014 |
|
|
Halobetasol
|
Mayne Pharma LLC |
5/21/2021 |
|
| Ibrutinib |
Pharmacyclics |
8/8/2022 |
|
| Ipilimumab |
BMS |
7/20/17 |
|
| Isavuconazonium sulfate |
Astellas Pharma US Inc. |
11/29/2023 |
|
| Ixabepilone |
BMS |
4/5/2011 |
|
Ivabradine |
Amgen |
3/30/2019 |
|
| Lanadelumab |
Takeda Pharmaceuticals U.S.A., Inc. |
12/20/2022 |
|
| Lansoprazole |
Tap Pharmaceutical Products, Inc. |
7/15/2008 |
|
| Lenvatinib Mesylate |
Eisai Inc. |
4/1/2024 |
|
| Levetiracetam |
UCB, Inc. |
6/3/2008 |
|
| Levocetirizine |
UCB, Inc. |
8/25/2009 |
|
| Linagliptin/Linagliptin and metformin hydrochloride |
Boehringer Ingelheim Pharmaceuticals |
6/9/2023 |
|
| Liraglutide |
Novo Nordisk |
5/1/2019 |
|
| Lisdexamfetamine |
Takeda Pharmaceuticals USA, Inc. |
7/27/2021 |
|
| Loteprednol/Tobramycin |
Bausch & Lomb |
12/28/2010 |
|
| Lopinavir/Ritonavir |
Abbott Laboratories |
3/7/2008 |
|
| Lumacaftor/Ivacaftor |
Vertex Pharmaceuticals Inc. |
12/11/2024 |
|
| Lurasidone |
Sunovion |
12/20/2016 |
|
| Lutetium Lu 177 dotatate |
Advanced Accelerator Applications |
4/19/2024 |
|
| Maraviroc |
ViiV Healthcare Co |
7/29/2020 |
|
| Memantine |
Forest Labs |
6/16/2014 |
|
Methylphenidate |
Rhodes Pharmaceuticals |
3/15/2019 |
|
| Micafungin |
Astellas |
11/14/2019 |
|
| Mirabegron |
Astellas Pharma Global Development, Inc. |
3/1/2021 |
|
| Mometasone/formoterol |
Merck |
6/24/2019 |
|
| Nilotinib |
Novartis |
3/20/2018 |
|
| Nintedanib |
Boehringer Ingelheim Pharmaceuticals |
10/6/2023 |
|
| Nitric Oxide |
INO Therapeutics |
11/2/2010 |
|
Nivolumab |
|
2/2/2023 |
|
| Olmesartan |
Daiichi Sankyo |
10/7/2009 |
|
| Olopatadine |
Alcon Research, Ltd. |
8/12/2009 |
|
| Olopatadine |
Alcon Research, Ltd. |
12/16/2014 |
|
| Paclitaxel |
Abraxis |
11/8/2019 |
|
| Paliperidone |
Ortho-McNeil-Janssen Pharmaceuticals, Inc. |
1/5/2011 |
|
| Palonosetron |
Helsinn |
4/10/2014 |
|
| Pantoprazole |
Wyeth Pharmaceuticals, Inc. |
2/17/2009 |
|
| Pemetrexed |
Eli Lilly |
12/3/2010 |
|
| Phenylephrine/Ketorolac |
Omeros |
12/6/2017 |
|
Pitavastatin |
Kowa Research Institute] |
3/30/2019 |
|
| Pomalidomide |
Celgene Corporation |
10/16/2020 |
|
| Prasugrel |
Eli Lilly |
5/23/16 |
|
| Quetiapine |
AstraZeneca Pharmaceuticals LP |
1/23/2009 |
|
| Rabeprazole |
Eisai |
12/4/2012 |
|
| Raltegravir |
Merck |
8/14/2017 |
|
| Remdesivir |
Gilead Sciences, Inc. |
January 23, 2024 |
|
| Rilpivirine |
Janssen Products, LP. |
1/18/2024 |
|
| Risedronate |
Procter & Gamble Pharmaceuticals, Inc. |
4/24/2009 |
|
| Rivaroxaban |
Janssen Pharmaceuticals, Inc. |
11/23/2021 |
|
| Rizatriptan |
Merck |
9/20/2011 |
|
| Rocuronium |
Organon, Inc. |
4/3/2008 |
|
| Rosuvastatin |
AstraZeneca Pharmaceuticals LP |
7/7/2009 |
|
| Rufinamide |
Eisai |
1/13/2015 |
|
| Ruxolitinib |
Incyte Corporation |
12/1/2022 |
|
| Sacubitril/Valsartan |
Novartis
|
9/26/2019 |
|
| Sapropterin |
BioMarin |
3/13/2014 |
|
| Saquinavir |
Hoffman-La Roche, Inc. |
10/26/2010 |
|
| Sildenafil |
Pfizer |
2/9/2012 |
|
| Sitagliptin |
Merck Sharp & Dohme Corp. |
10/30/2020 |
|
| Sofosbuvir |
Gilead Sciences, Inc. |
7/23/2019 |
|
| Sofosbuvir/Ledipasvir |
Gilead Sciences, Inc. |
7/23/2019 |
|
Sofosbuvir/Velpatasvir |
Gilead Sciences, Inc. |
5/13/2021 |
|
| Solifenacin |
Astellas |
7/20/2017 |
|
| Sugammadex |
Merck, Sharp & Dohme LLC (Merck) |
12/9/2024 |
|
| Sumatriptan/Naproxen |
GlaxoSmithKline/Pernix |
4/16/2015 |
|
| Tadalafil |
Eli Lilly |
11/16/2017 |
|
| Tamsulosin |
Boehringer Ingelheim |
9/17/2009 |
|
| Tapentadol |
Collegium Pharmaceutical Inc. |
June 11, 2024 |
|
| Tavaborole |
Anacor |
7/18/2018 |
|
| Tbo-filgrastim |
Sicor |
7/18/2018 |
|
| Technetium Tc99 sestamibi |
BMS |
1/11/2008 |
|
| Teduglutide |
Shire – NPS Pharmaceuticals |
3/7/2019 |
|
| Temsirolimus |
Pfizer |
2/28/2012 |
|
| Tenofovir |
Gilead Sciences, Inc. |
9/6/2011 |
|
Tenofovir |
Gilead Sciences, Inc. |
11/15/2018 |
|
| Teriflunomide |
Sanofi Aventis |
3/31/2021 |
|
| Ticagrelor |
AstraZeneca |
4/8/2022 |
|
| Tiotropium |
Boehringer Ingelheim Pharmaceuticals, Inc. |
12/14/16 |
|
| Tipranavir |
Boehringer Ingelheim Pharmaceuticals, Inc. |
3/7/2008 |
|
| Tocilizumab |
Genentech/Hoffmann-La Roche |
7/18/2018 |
|
| Tofacitinib NEW |
Pfizer, Inc |
02/19/2025 |
|
| Topiramate |
Ortho-McNeil-Janssen Pharmaceuticals, Inc. |
7/24/2008 |
|
| Trabectedin |
Janssen |
6/12/2018 |
|
| Trametinib |
Novartis |
2/9/2023 |
|
| Valacyclovir |
GlaxoSmithKline |
2/28/2008 |
|
| Valganciclovir |
Hoffman-La Roche Inc. |
7/24/2008 |
|
| Valproate |
Abbott |
12/14/2007 |
|
Varenicline |
Pfizer |
11/15/2018 |
|
| Vigabatrin |
Lundbeck |
10/3/2013 |
|
| Vilazodone |
Allergan |
1/21/2020 |
|
| Vortioxetine |
Takeda Pharmaceuticals USA Inc. |
8/21/2023 |
|
| Zoledronic acid |
Novartis |
12/21/2007 |
|
Source